Department of Biochemistry, BLDEAS Shri B.M. Patil Medical College, Bijapur, India.
Indian J Pharmacol. 2008 Aug;40(4):158-63. doi: 10.4103/0253-7613.43162.
To study the effect of the methomyl on mixed function oxidase system in rats.
The effect of the methomyl on mixed function oxidase was studied using different dosages, durations and sex. Microsomes were isolated using the calcium precipitation method. The levels of cytochrome P(450) , and cytochrome b(5) were determined using extinction coefficient of 91 and 85 mM(-1) respectively. The activities of drug metabolizing enzymes, hemoglobin content, liver function enzymes, and serum cholinesterase activity were assayed by using standard methods.
Intraperitoneal administration of methomyl (4 mg/kg body weight) showed significant decrease in the level of cytochrome P(450) , and the activities of aminopyrine N-demethylase and aniline hydroxylase on the third day of the treatment. Methomyl (4 mg/kg) treatment of old male rat and adult female rat also showed a decrease in the level of cytochrome P(450) , and aminopyrine N-demethylase activity. The serum samples from methomyl treated rats (male and female), when analyzed for alanine aminotransferase (SGPT) and aspartate aminotransferase (SGOT) as markers of the liver toxicity, showed significant increase in the activity. The activities of SGPT and SGOT were significantly higher in the treated rats (2 and 4 mg/kg) than in the control group. A significant decrease in the level of hemoglobin and serum cholinesterase activity was observed, when there was an increase in the dose level. A significant increase was observed in alkaline phosphatase activity at all dose levels.
Methomyl influences mixed function oxidase and creates abnormality of liver functions in the rats. This effect depends on the dose and duration of methomyl.
研究灭多威对大鼠混合功能氧化酶系统的影响。
采用不同剂量、时间和性别研究灭多威对混合功能氧化酶的影响。用钙沉淀法分离微粒体。用 91 和 85mM(-1)的消光系数分别测定细胞色素 P(450)和细胞色素 b(5)的水平。用标准方法测定药物代谢酶、血红蛋白含量、肝功能酶和血清胆碱酯酶活性。
腹腔内给予灭多威(4mg/kg 体重),第 3 天治疗时细胞色素 P(450)水平和氨基比林 N-脱甲基酶、苯胺羟化酶活性明显下降。老年雄性大鼠和成年雌性大鼠用灭多威(4mg/kg)治疗也显示细胞色素 P(450)水平和氨基比林 N-脱甲基酶活性下降。用灭多威处理的大鼠(雄性和雌性)血清样品分析丙氨酸氨基转移酶(SGPT)和天冬氨酸氨基转移酶(SGOT)作为肝毒性标志物时,其活性明显增加。与对照组相比,2mg/kg 和 4mg/kg 处理组的 SGPT 和 SGOT 活性显著升高。血红蛋白和血清胆碱酯酶活性水平随剂量水平的增加而显著降低,碱性磷酸酶活性在所有剂量水平均显著升高。
灭多威影响混合功能氧化酶,并导致大鼠肝功能异常。这种影响取决于灭多威的剂量和时间。